This approach would aim to raise the same amount of revenue that was previously generated by covered entities’ arbitrage of ...

A program that started in the early nineties meant to help low-income patients, is at the forefront. But some worry that ...

Lawmakers impatient with the lack of progress on a key health care issue — the long-debated need for changes to what’s known ...

The Health Resources and Services Administration has approved eight manufacturer rebate plans under a new 340B pilot program set to launch Jan. 1. The initiative will replace upfront drug discounts ...

WASHINGTON - A Senate health committee met last week to scrutinize the 340B Program, an initiative intended to foster the ...

Drugs that will be subject to rebates in 340B next year include Bristol Myers Squibb’s Eliquis, Johnson & Johnson’s Stelara ...

Former Congressional Budget Office Director Dan Crippen argues the 340B discount program is overdue for reform.

Lawmakers called for more transparency about how hospitals are using 340B revenue, including audits of participating ...

Lawmakers across the country are working through bills written to shield a growing source of revenue for hospital systems and ...

If drugmakers have their way, the federal government likely ends up spending $100 billion of taxpayer funds to bail out rural hospitals.

The 340B program was established by Congress in 1992 to provide steep discounts to hospitals that serve a large proportion of ...

The US Health Resources and Services Administration (HRSA) has approved nine drugs for a pilot testing a new rebate model ...